Eric H. Liu

Oncology

1800 Williams St
Ste 200
Denver, CO 80218

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Natural Phytochemicals as Inhibitors of HIF-1α in Breast Cancer: Review of Preclinical Evidence and Future Prospects.

Natural Phytochemicals as Inhibitors of HIF-1α in Breast Cancer: Review of Preclinical Evidence and Future Prospects.

Journal: Current issues in molecular biology

Published: November 25, 2025

Histotripsy for neuroendocrine liver metastases: Early single-institution outcomes and safety.

Histotripsy for neuroendocrine liver metastases: Early single-institution outcomes and safety.

Journal: Surgery

Published: September 01, 2025

Pancreatic Neuroendocrine Tumors and Lymph Nodes: How Much Surgery is Enough?

Pancreatic Neuroendocrine Tumors and Lymph Nodes: How Much Surgery is Enough?

Journal: Annals of surgical oncology

Published: December 27, 2023

Breakthrough Symptoms Remain an Unmet Need in Symptomatic Patients With Neuroendocrine Tumors and Carcinoid Syndrome.

Breakthrough Symptoms Remain an Unmet Need in Symptomatic Patients With Neuroendocrine Tumors and Carcinoid Syndrome.

Journal: Pancreas

Published: June 28, 2023

Lanreotide Depot to Treat Gastroenteropancreatic Neuroendocrine Tumors in a US Community Oncology Setting: A Prospective, Observational Study.

Lanreotide Depot to Treat Gastroenteropancreatic Neuroendocrine Tumors in a US Community Oncology Setting: A Prospective, Observational Study.

Journal: Oncology and therapy

Published: July 05, 2022

Antiproliferative Effects of Telotristat Ethyl in Patients with Neuroendocrine Tumors: The TELEACE Real-World Chart Review Study.

Antiproliferative Effects of Telotristat Ethyl in Patients with Neuroendocrine Tumors: The TELEACE Real-World Chart Review Study.

Journal: Cancer management and research

Published: May 06, 2020

Current Practices and Novel Techniques in the Diagnosis and Management of Neuroendocrine Tumors of Unknown Primary.

Current Practices and Novel Techniques in the Diagnosis and Management of Neuroendocrine Tumors of Unknown Primary.

Journal: Pancreas

Published: October 15, 2019

Hepatic micrometastases are associated with poor prognosis in patients with liver metastases from neuroendocrine tumors of the digestive tract.

Hepatic micrometastases are associated with poor prognosis in patients with liver metastases from neuroendocrine tumors of the digestive tract.

Journal: Human pathology

Published: February 20, 2018

The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society.

The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society.

Journal: Pancreas

Published: June 14, 2017

In liver metastases from small intestinal neuroendocrine tumors, SSTR2A expression is heterogeneous.

In liver metastases from small intestinal neuroendocrine tumors, SSTR2A expression is heterogeneous.

Journal: Virchows Archiv : an international journal of pathology

Published: October 19, 2016

Mesenteric Tumor Deposits in Midgut Small Intestinal Neuroendocrine Tumors Are a Stronger Indicator Than Lymph Node Metastasis for Liver Metastasis and Poor Prognosis.

Mesenteric Tumor Deposits in Midgut Small Intestinal Neuroendocrine Tumors Are a Stronger Indicator Than Lymph Node Metastasis for Liver Metastasis and Poor Prognosis.

Journal: The American journal of surgical pathology

Published: September 30, 2016

Expression of CD24, a Stem Cell Marker, in Pancreatic and Small Intestinal Neuroendocrine Tumors.

Expression of CD24, a Stem Cell Marker, in Pancreatic and Small Intestinal Neuroendocrine Tumors.

Journal: American journal of clinical pathology

Published: September 20, 2015

Showing 1-12 of 18

Last Updated: 09/26/2026